In this context, our results suggest it would be worthwhile to study whether these pharmacologic agents or other anti-inflammatory drugs might also prevent the RA-related bone loss inhibiting the RANKL expression in cartilage. This evidence concerns the gene TNFSF11 and rheumatoid arthritis.